Bitcoin groundbreakers share personal stories of how Bitcoin is changing lives for the better. Host Mauricio Di Bartolomeo, co-founder and CSO of Ledn, speaks with leading Bitcoin voices, entrepreneurs, and human rights advocates to hear their unique journey and practical real-world examples of how Bitcoin has made a positive impact in their lives. Brought to you by Ledn, a leading financial services company built for Bitcoin & digital assets. Ledn offers a suite of lending, saving and tradi ...
…
continue reading
المحتوى المقدم من jruss88 and Vox Markets Podcast. يتم تحميل جميع محتويات البودكاست بما في ذلك الحلقات والرسومات وأوصاف البودكاست وتقديمها مباشرةً بواسطة jruss88 and Vox Markets Podcast أو شريك منصة البودكاست الخاص بهم. إذا كنت تعتقد أن شخصًا ما يستخدم عملك المحمي بحقوق الطبع والنشر دون إذنك، فيمكنك اتباع العملية الموضحة هنا https://ar.player.fm/legal.
Player FM - تطبيق بودكاست
انتقل إلى وضع عدم الاتصال باستخدام تطبيق Player FM !
انتقل إلى وضع عدم الاتصال باستخدام تطبيق Player FM !
1034: Dr Mike Hudson of EDX Medical: Collaboration accelerates access to highly reliable, affordable tests for a range of cancers in the UK & Europe
MP3•منزل الحلقة
Manage episode 347633559 series 2936804
المحتوى المقدم من jruss88 and Vox Markets Podcast. يتم تحميل جميع محتويات البودكاست بما في ذلك الحلقات والرسومات وأوصاف البودكاست وتقديمها مباشرةً بواسطة jruss88 and Vox Markets Podcast أو شريك منصة البودكاست الخاص بهم. إذا كنت تعتقد أن شخصًا ما يستخدم عملك المحمي بحقوق الطبع والنشر دون إذنك، فيمكنك اتباع العملية الموضحة هنا https://ar.player.fm/legal.
Dr Mike Hudson, CEO of EDX Medical Group #EDX discusses their collaboration with Tianjin Bioscience Diagnostic Technology Co. Ltd which will accelerate access to highly reliable, affordable tests for a range of cancers in the UK & Europe.
Highlights
The programme is a result of a partnership between the Company and Tianjin Bioscience Diagnostic Technology Co. Ltd ("Bioscience"), an internationally active, ISO 13485-certified research-based manufacturer of diagnostic products and reagents. The Company has been selected by Bioscience as its lead partner to validate and commercialise its suite of internationally recognised cancer biomarkers in Europe.
The programme will encompass the validation and clinical deployment of Bioscience's digital chemiluminescence immunoassay technology for an initial 10 cancer biomarkers, including the key glycoprotein Carbohydrate Antigens: CA-15-3, CA19-9, CA-125, and CA-72-4. These biomarkers are recognised as important tools to improve the clinical management of a range of cancers and will be deployed both individually and in combination using the Bioscience automated analysers.
To read the full RNS click here
Highlights
The programme is a result of a partnership between the Company and Tianjin Bioscience Diagnostic Technology Co. Ltd ("Bioscience"), an internationally active, ISO 13485-certified research-based manufacturer of diagnostic products and reagents. The Company has been selected by Bioscience as its lead partner to validate and commercialise its suite of internationally recognised cancer biomarkers in Europe.
The programme will encompass the validation and clinical deployment of Bioscience's digital chemiluminescence immunoassay technology for an initial 10 cancer biomarkers, including the key glycoprotein Carbohydrate Antigens: CA-15-3, CA19-9, CA-125, and CA-72-4. These biomarkers are recognised as important tools to improve the clinical management of a range of cancers and will be deployed both individually and in combination using the Bioscience automated analysers.
To read the full RNS click here
1848 حلقات
MP3•منزل الحلقة
Manage episode 347633559 series 2936804
المحتوى المقدم من jruss88 and Vox Markets Podcast. يتم تحميل جميع محتويات البودكاست بما في ذلك الحلقات والرسومات وأوصاف البودكاست وتقديمها مباشرةً بواسطة jruss88 and Vox Markets Podcast أو شريك منصة البودكاست الخاص بهم. إذا كنت تعتقد أن شخصًا ما يستخدم عملك المحمي بحقوق الطبع والنشر دون إذنك، فيمكنك اتباع العملية الموضحة هنا https://ar.player.fm/legal.
Dr Mike Hudson, CEO of EDX Medical Group #EDX discusses their collaboration with Tianjin Bioscience Diagnostic Technology Co. Ltd which will accelerate access to highly reliable, affordable tests for a range of cancers in the UK & Europe.
Highlights
The programme is a result of a partnership between the Company and Tianjin Bioscience Diagnostic Technology Co. Ltd ("Bioscience"), an internationally active, ISO 13485-certified research-based manufacturer of diagnostic products and reagents. The Company has been selected by Bioscience as its lead partner to validate and commercialise its suite of internationally recognised cancer biomarkers in Europe.
The programme will encompass the validation and clinical deployment of Bioscience's digital chemiluminescence immunoassay technology for an initial 10 cancer biomarkers, including the key glycoprotein Carbohydrate Antigens: CA-15-3, CA19-9, CA-125, and CA-72-4. These biomarkers are recognised as important tools to improve the clinical management of a range of cancers and will be deployed both individually and in combination using the Bioscience automated analysers.
To read the full RNS click here
Highlights
The programme is a result of a partnership between the Company and Tianjin Bioscience Diagnostic Technology Co. Ltd ("Bioscience"), an internationally active, ISO 13485-certified research-based manufacturer of diagnostic products and reagents. The Company has been selected by Bioscience as its lead partner to validate and commercialise its suite of internationally recognised cancer biomarkers in Europe.
The programme will encompass the validation and clinical deployment of Bioscience's digital chemiluminescence immunoassay technology for an initial 10 cancer biomarkers, including the key glycoprotein Carbohydrate Antigens: CA-15-3, CA19-9, CA-125, and CA-72-4. These biomarkers are recognised as important tools to improve the clinical management of a range of cancers and will be deployed both individually and in combination using the Bioscience automated analysers.
To read the full RNS click here
1848 حلقات
كل الحلقات
×مرحبًا بك في مشغل أف ام!
يقوم برنامج مشغل أف أم بمسح الويب للحصول على بودكاست عالية الجودة لتستمتع بها الآن. إنه أفضل تطبيق بودكاست ويعمل على أجهزة اندرويد والأيفون والويب. قم بالتسجيل لمزامنة الاشتراكات عبر الأجهزة.